INSIGHTS ON REGULATORY COMPLIANCE
-
![icellis 50]( "Scale Your Viral Vector Production With A Streamlined Bioreactor System")
Scale Your Viral Vector Production With A Streamlined Bioreactor SystemScale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.
-
![GettyImages-949947192 lab, data]( "Maximize Your Laboratory Efficiency")
Maximize Your Laboratory EfficiencyGain insight into how labs can boost productivity by reducing downtime, minimizing errors, and increasing walk-away time through real-time insights and analytics.
-
![Cell Therapy Process Cevelopment Made Easy]( "Cell Therapy Process Development Made Easy")
Cell Therapy Process Development Made EasyExplore how Fast Trak™ process development services offered by Cytiva can guide you through achieving GMP compliance in your cell therapy manufacturing process.
-
![iStock-1067806062-vial-development-manufacturing]( "The Influence Of Economic Factors On Biopharmaceutical Manufacturing")
The Influence Of Economic Factors On Biopharmaceutical ManufacturingUnderstanding the complex effects of inflation, recession, and regulatory shifts is key to navigating the challenges faced by the biopharmaceutical manufacturing sector and ensuring its continued growth.
-
How Intelligent Automation Transforms CQV Workflows7/23/2025
Discover how intelligent automation is revolutionizing CQV in life sciences to eliminate manual bottlenecks, accelerate timelines, and enhance compliance in an era of increasing regulatory scrutiny.
-
Comprehensive Regulatory Support8/29/2024
Review our expertise across a wide range of global markets. Our experience in securing regulatory approvals and navigating market challenges positions us as a trusted partner.
-
What Happens When You Refuse To Compromise On Sustainability?8/8/2025
Discover how an empty building shell became a sustainable nanomedicine hub and achieved 47% energy savings and 88% fewer emissions, which sets new standards for innovation in the biologics industry.
-
Bioequivalence In Topical Generics: Regulatory Considerations9/2/2025
Regulators are increasingly favoring in vitro methods to prove bioequivalence, though differing guidelines and a new focus on matching reference product structures pose challenges.
-
Strategies For QA Professionals In Life Sciences7/14/2025
Explore challenges QA professionals face in document reviews and expert strategies to boost accuracy, streamline workflows, and ensure compliance with evolving regulatory standards.
REGULATORY COMPLIANCE SOLUTIONS
-
![MinicapProE]( "Remote Cleanroom Microbial Air Sampler (Annex 1-Compliant)")
The MiniCapt® Pro Remote Microbial Air Sampler from Particle Measuring Systems (PMS) incorporates the latest viable cleanroom monitoring technologies into one instrument to customize cleanroom and aseptic area microbial monitoring according to ISO Class 5/7, GMP Grade A/B, and for use in background areas monitored by a Facility Monitoring System (FMS).
-
![Scientist working in laboratory-GettyImages-2215842283]( "High-Purity Analytical Solvents: Consistent Quality For Applicants")
Minimize variability and improve detection confidence with high-purity analytical solvents. Discover how tightly controlled specifications support cleaner baselines and more reliable results.
-
![Genedata Selector]( "Manage, Analyze, And Visualize Sequencing Data")
Simplify NGS workflows with a platform that automates analysis, integrates diverse data types, and supports GMP validation to extract meaningful insights and streamline regulatory documentation.
-
![GettyImages-1370928101 regulatory compliance]( "Biological Indicator Testing: Meeting Regulatory Demands With Confidence")
Explore cycle development and validation services and biological indicator testing services from an ISO-certified laboratory, registered with the FDA and DEA.
-
![PO 3 - GCApp_Stereo Microscope (person with blue coat)]( "Minimizing Uncertainty Throughout The Development Lifecycle")
Wearable technologies that allow for dosing of high-volume biologics over a longer time need to be designed with manufacturability end-user needs in mind and must comply with the highest quality and regulatory standards.
